Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9505784 Fused 2-aminothiazole compounds

Patent 9505784 was granted and assigned to Dana-Farber Cancer Institute on November, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
July 1, 2014
Date of Patent
November 29, 2016
Patent Application Number
14321242
Patent Citations Received
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
‌
US Patent 11802126 Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9505784
Patent Primary Examiner
‌
Nyeemah A Grazier

Find more entities like US Patent 9505784 Fused 2-aminothiazole compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo